Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.
about
Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care?Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessmentConcerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.A Novel WRN Frameshift Mutation Identified by Multiplex Genetic Testing in a Family with Multiple Cases of CancerUnderstanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise of Peer Support.Cancer genomics and inherited risk.Current and future intratumoral targeted treatment for pancreatic cancer.The future of clinical cancer genomics.The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.Cost Implications of Value-Based Pricing for Companion Diagnostic Tests in Precision Medicine.The changing landscape of hereditary cancer genetic testing.Myriad's impact on gene patents.Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer.
P2860
Q27026343-D3AF3E31-954C-4970-B8C3-9D8022581028Q33796155-DBF39648-78D3-42D0-A2C0-8A9785DA9649Q35563836-E6EB26C9-CE3D-4254-BFB8-160DEA597697Q35737508-6E4867A3-F0ED-455F-8256-AED2B288D1F0Q37293888-8E860E9A-3CA4-4211-9001-EF62CA358887Q38180646-40CDD701-D479-4F9F-B3F4-97BF5C6BE03BQ38261961-9D5AA189-24A6-4EFA-88E9-BE28657D0DB0Q38789283-72E79575-BA56-40EA-8F2C-4EAD39A31CD4Q38821634-07A57275-693C-47CA-A652-5F2A554EA652Q38840457-C190252D-46ED-4EA3-9375-47B13A4E8DFDQ39980317-A41F5E83-694E-4B93-AAB2-5E8C862D924BQ48369392-5D3E1F5E-B9F7-4BED-9F6D-83292A69B4AFQ51104925-713FD734-AC5D-422A-A944-2E1395210FBDQ52660922-2E07D01E-1157-4493-9704-38CFF5D9928C
P2860
Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Gene patents and personalized ...... iad case on clinical oncology.
@en
Gene patents and personalized ...... iad case on clinical oncology.
@nl
type
label
Gene patents and personalized ...... iad case on clinical oncology.
@en
Gene patents and personalized ...... iad case on clinical oncology.
@nl
prefLabel
Gene patents and personalized ...... iad case on clinical oncology.
@en
Gene patents and personalized ...... iad case on clinical oncology.
@nl
P2093
P2860
P356
P1476
Gene patents and personalized ...... iad case on clinical oncology.
@en
P2093
Angela Bradbury
Courtney Storm
Jon F Merz
Kevin E Noonan
Rebecca Spence
P2860
P304
P356
10.1200/JCO.2013.49.7388
P407
P577
2013-06-13T00:00:00Z